Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Sanofi India Limited
  6. News
  7. Summary
    500674   INE058A01010

SANOFI INDIA LIMITED

(500674)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sanofi India to Sell Two Brands to Topical Formulation Manufacturer

11/26/2021 | 03:53am EST


ę MT Newswires 2021
All news about SANOFI INDIA LIMITED
01/13Sanofi India's Managing Director to Step Down in April
MT
2021Sanofi India to Sell Two Brands to Topical Formulation Manufacturer
MT
2021Sanofi India Limited Announces Resignation of Cyril Grandchamp-Desraux as Non-Executive..
CI
2021Sanofi India Limited Announces Appointment of Radhika Shah as Company Secretary and Com..
CI
2021Sanofi India's Net Profit Soars in Q3
MT
2021Sanofi India Limited Reports Earnings Results for the Third Quarter and Nine Months End..
CI
2021SANOFI INDIA : Completes Sale of Nutraceuticals Business
MT
2021Universal Nutriscience Private Limited completed the acquisition of Nutraceuticals Busi..
CI
2021Sanofi India Limited Announces Executive Changes
CI
2021SANOFI INDIA : to Sell Nutraceuticals Business for $79 Million
MT
More news
Financials
Sales 2021 28 944 M 385 M 385 M
Net income 2021 8 945 M 119 M 119 M
Net Debt 2021 - - -
P/E ratio 2021 27,7x
Yield 2021 5,21%
Capitalization 161 B 2 144 M 2 147 M
Capi. / Sales 2021 5,57x
Capi. / Sales 2022 5,33x
Nbr of Employees 2 912
Free-Float -
Chart SANOFI INDIA LIMITED
Duration : Period :
Sanofi India Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI INDIA LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 7 004,20 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Rajaram Narayanan Executive Director
Vaibhav Karandikar Chief Financial officer & Executive Director
Aditya Narayan Chairman
Shalini Menon Director-Country Medical
Radhika Vishal Shah Secretary & Compliance Officer